TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34053250

Group type: EXPERIMENTAL
Intervention: Dual-task (DT) walking intervention
Number of subjects: 45

Group type: COMPARATOR
Intervention: Single-task (ST) walking intervention
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: fNIRS measurement during DT walking
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: fMRI analysis
Number of subjects: 45
Study: 35428615

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Sham electroacupuncture
Number of subjects: 248
Study: 33141790

Group type: EXPERIMENTAL
Intervention: CSM-based intervention consisting of five weekly group-based education sessions
Number of subjects: 455

Group type: COMPARATOR
Intervention: Control group receiving five weekly educational booklets
Number of subjects: 455
Study: 32843718

Group type: EXPERIMENTAL
Intervention: Community-based lifestyle intervention program with face-to-face educational sessions
Number of subjects: 9204

Group type: EXPERIMENTAL
Intervention: Community-based lifestyle intervention program
Number of subjects: 9204

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 9204
Study: 34971596

Group type: EXPERIMENTAL
Intervention: Graded Exposure Therapy (GET)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Operant Condition‐Based Pacing Strategies plus Mindfulness Training (Pacing+)
Number of subjects: 73
Study: 32411324

Group type: EXPERIMENTAL
Intervention: L-Glutamine (Gln) supplementation
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: L-Glutamine (Gln) supplementation in CET group
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: L-Glutamine (Gln) supplementation in NP group
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo (PL) in NP group
Number of subjects: 83

Group type: COMPARATOR
Intervention: Combined-Exercise Training (CET)
Number of subjects: 83

Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 83
Study: 33051793

Group type: EXPERIMENTAL
Intervention: Low-pressure occlusion group (LPO)
Number of subjects: 33

Group type: COMPARATOR
Intervention: High-pressure occlusion group (HPO)
Number of subjects: 33
Study: 33245000

Group type: EXPERIMENTAL
Intervention: FindMyApps intervention (n=28)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (n=31)
Number of subjects: 59
Study: 34000958

Group type: EXPERIMENTAL
Intervention: Faecal microbiota transplantation (FMT) capsules for 12 days
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo capsules for 12 days
Number of subjects: 52
Study: 35907867

Group type: EXPERIMENTAL
Intervention: 24-month physical activity intervention with in-person classes, social support, and environmental changes led by community health workers (promotoras)
Number of subjects: 436

Group type: COMPARATOR
Intervention: Attention-control condition
Number of subjects: 436
Study: 33743647

Group type: EXPERIMENTAL
Intervention: Sa‐Chan Japan (animation)
Number of subjects: 1002

Group type: COMPARATOR
Intervention: Mari Info Japan (control animation)
Number of subjects: 1002
Study: 32919779

Group type: EXPERIMENTAL
Intervention: Aspirin use (≥once/week)
Number of subjects: 41633

Group type: EXPERIMENTAL
Intervention: Daily use of aspirin
Number of subjects: 41633

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin
Number of subjects: 41633

Group type: EXPERIMENTAL
Intervention: Daily use of low-dose aspirin
Number of subjects: 41633
Study: 35476631

Group type: EXPERIMENTAL
Intervention: 8 mg moxidectin
Number of subjects: 0

Group type: COMPARATOR
Intervention: 150 μg/kg ivermectin
Number of subjects: 0
Study: 34418361

Group type: EXPERIMENTAL
Intervention: Inhaled budesonide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 33988332

Group type: EXPERIMENTAL
Intervention: tSFE
Number of subjects: 56

Group type: COMPARATOR
Intervention: lSFE
Number of subjects: 56
Study: 32175586

Group type: EXPERIMENTAL
Intervention: Acetazolamide (AZ) 250 mg twice daily for 3.5 days
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 33325645

Group type: EXPERIMENTAL
Intervention: COMB (canagliflozin plus teneligliptin)
Number of subjects: 0

Group type: COMPARATOR
Intervention: SWITCH (switching from teneligliptin to canagliflozin)
Number of subjects: 0
Study: 32720823

Group type: EXPERIMENTAL
Intervention: Colchicine 1 mg orally 12 to 24 hours before surgery followed by 0.5 mg daily until discharge
Number of subjects: 152

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 152
Study: 35300888

Group type: EXPERIMENTAL
Intervention: Thulium fibre laser (TFL)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Holmium: YAG (Ho:YAG)
Number of subjects: 120
Study: 33479775

Group type: EXPERIMENTAL
Intervention: Adjunctive 1000 mg aspirin
Number of subjects: 360

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 360
Study: 32598248

Group type: EXPERIMENTAL
Intervention: Poloxamer-188 (0.94%), chitosan (2.38%), swelling time (1.81 h), parts of chitosan (78.51%)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Chitosan and Poloxamer-188 concentrations
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: In-silico screening methodology
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Mathematical fitting and analysis
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Drug-polymer interaction study
Number of subjects: 8
Study: 34262711

Group type: EXPERIMENTAL
Intervention: Food ration bars enriched with arginine (2 g/day), ß‐alanine (2 g/day), and Nigella sativa (2 g/day)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Nonenriched food ration bars
Number of subjects: 54
Study: 32367114

Group type: EXPERIMENTAL
Intervention: Esketamine + antidepressant
Number of subjects: 0

Group type: COMPARATOR
Intervention: Antidepressant + placebo
Number of subjects: 0
Study: 34569129

Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation for 6 weeks
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 72
Study: 32966685

Group type: EXPERIMENTAL
Intervention: Moderate diet-induced weight loss
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal-weight participants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Obese participants before weight loss
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Obese participants after weight loss
Number of subjects: 0
Study: 33276689

Group type: EXPERIMENTAL
Intervention: Nevirapine (NVP)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 2-hydroxynevirapine
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 3-hydroxynevirapine
Number of subjects: 75
Study: 33921327

Group type: EXPERIMENTAL
Intervention: Community-based care prevention, functional training exercise program
Number of subjects: 1509
Study: 35476942

Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy (SBRT, 30 Gy/3 fx)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Whole pelvic radiotherapy (WPRT, 45 Gy/25 fx + SIB boost to 65 Gy)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy (SBRT)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Whole pelvic radiotherapy (WPRT)
Number of subjects: 24
Study: 36191080

Group type: EXPERIMENTAL
Intervention: GSK3732394 (10 mg starting dose, single ascending doses)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: GSK3732394 (maximum dose 80 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 33727632

Group type: COMPARATOR
Intervention: 150 min/week (low-volume) aerobic exercise
Number of subjects: 720

Group type: COMPARATOR
Intervention: 225 min/week (mid-volume) aerobic exercise
Number of subjects: 720

Group type: COMPARATOR
Intervention: 300 min/week (high-volume) aerobic exercise
Number of subjects: 720
Study: 34389168

Group type: EXPERIMENTAL
Intervention: Goal-directed fluid therapy (GDT group)
Number of subjects: 312

Group type: COMPARATOR
Intervention: Standard intravenous fluid therapy (STD group)
Number of subjects: 312
Study: 33216664

Group type: EXPERIMENTAL
Intervention: Error-minimized powered wheelchair skills training program (Co-pilot) - 6 sessions
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Error-minimized powered wheelchair skills training program (Co-pilot) - 12 sessions
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control intervention - 6 sessions
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control intervention - 12 sessions
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Error-minimized powered wheelchair skills training program (Co-pilot)
Number of subjects: 25
Study: 35190827

Group type: EXPERIMENTAL
Intervention: Interactive education
Number of subjects: 140

Group type: COMPARATOR
Intervention: Didactic education (control)
Number of subjects: 140
Study: 33926423

Group type: EXPERIMENTAL
Intervention: Double combination of oral OADs (sulfonylurea and thiazolidinediones)
Number of subjects: 3355

Group type: EXPERIMENTAL
Intervention: Triple combination of oral OADs (metformin, sulfonylurea, and thiazolidinediones)
Number of subjects: 3355
Study: 32661909

Group type: EXPERIMENTAL
Intervention: Elacestrant 200 mg daily
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Elacestrant 500 mg daily
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Elacestrant (up to 1000 mg daily)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Elacestrant (500 mg dose)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Elacestrant (200 mg dose)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study: 35042918

Group type: EXPERIMENTAL
Intervention: Trabecular Metal (porous tantalum coating)
Number of subjects: 118

Group type: COMPARATOR
Intervention: VerSys (fiber mesh coating)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 118
Study: 34772339

Group type: EXPERIMENTAL
Intervention: Multimedia education
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Multimedia education together with teach-back method
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study: 32613433

Group type: EXPERIMENTAL
Intervention: A-PRF+
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: L-PRF
Number of subjects: 102

Group type: COMPARATOR
Intervention: Suture alone
Number of subjects: 102
Study: 32759285

Group type: EXPERIMENTAL
Intervention: Freeze-all group (elective freezing of all embryos) with gonadotropin releasing hormone agonist triggering and single frozen-thawed blastocyst transfer in a subsequent modified natural cycle.
Number of subjects: 460

Group type: COMPARATOR
Intervention: Fresh transfer group with human chorionic gonadotropin triggering and single blastocyst transfer in the fresh cycle.
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Freeze-all group
Number of subjects: 460

Group type: COMPARATOR
Intervention: Fresh transfer group
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 460
Study: 32223966

Group type: EXPERIMENTAL
Intervention: Higher IL‐1ra levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher IL‐6 levels (reduced bio-function)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IL‐1ra
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IL‐6
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IL‐16
Number of subjects: 0
Study: 35585787

Group type: EXPERIMENTAL
Intervention: Direct lateral approach
Number of subjects: 150

Group type: COMPARATOR
Intervention: Anterolateral approach
Number of subjects: 150
Study: 33038677

Group type: EXPERIMENTAL
Intervention: Rethink Vape Materials
Number of subjects: 268

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 268
Study: 33092401

Group type: EXPERIMENTAL
Intervention: MAVIG X-ray protective drape (MXPD)
Number of subjects: 632
Study: 35598008

Group type: EXPERIMENTAL
Intervention: Metformin hydrochloride sustained-release tablets (0.5 g/day for the first 2 weeks, 1 g/day for the second 2 weeks, and 2 g/day for the remaining period if tolerated)
Number of subjects: 262

Group type: COMPARATOR
Intervention: Placebo (identical inert placebo)
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Metformin hydrochloride sustained-release tablets
Number of subjects: 262
Study: 33607697

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No mindfulness training (control)
Number of subjects: 0
Study: 36397220

Group type: EXPERIMENTAL
Intervention: Auricular point sticking combined with TEAS (Lieque [LU 7] and Zusanli [ST 36], continuous wave, 20 Hz, 1 mA, 30 min each time, once a day)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Nicotine patch
Number of subjects: 200
Study: 35182665

Group type: EXPERIMENTAL
Intervention: Yi-Gan-san (YGS)
Number of subjects: 38

Group type: COMPARATOR
Intervention: YGS placebo
Number of subjects: 38
Study: 35291399

Group type: EXPERIMENTAL
Intervention: Bupivacaine 2.5 mg/mL 20 mL plus dexmedetomidine 100 µg
Number of subjects: 42

Group type: COMPARATOR
Intervention: Bupivacaine 20 mL alone
Number of subjects: 42
Study: 36126050

Group type: EXPERIMENTAL
Intervention: Web‐based application for a specific 9‐week intervention in depression and type 1 diabetes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting list (control group)
Number of subjects: 0
Study: 36329553

Group type: EXPERIMENTAL
Intervention: Genistein 120 mg daily for 12 months
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 32034285

Group type: EXPERIMENTAL
Intervention: LEN-CR (lenalidomide maintenance until achievement of complete response)
Number of subjects: 502

Group type: COMPARATOR
Intervention: LEN-2Y (lenalidomide maintenance for a fixed duration of 2 years)
Number of subjects: 502
Study: 34679188

Group type: EXPERIMENTAL
Intervention: Libre del Cigarrillo (LDC) - 11 booklets and 9 pamphlets mailed monthly over 18 months
Number of subjects: 1417

Group type: COMPARATOR
Intervention: Usual Care (UC) - a single Spanish‐language self‐help booklet from the National Cancer Institute
Number of subjects: 1417
Study: 33358235

Group type: EXPERIMENTAL
Intervention: Alendronate plus alfacalcidol
Number of subjects: 412

Group type: COMPARATOR
Intervention: Alendronate alone
Number of subjects: 412
Study: 32371690

Group type: EXPERIMENTAL
Intervention: Regional nerve blockade (RNB)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Local infiltration anesthesia
Number of subjects: 32
Study: 35191716

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral couple therapy (CBCT) for 12 weeks
Number of subjects: 108

Group type: COMPARATOR
Intervention: Lidocaine treatment for 12 weeks
Number of subjects: 108
Study: 34295153

Group type: EXPERIMENTAL
Intervention: Hand holding with relatives (HR)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Hand holding with strangers (HS)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study: 32470863

Group type: EXPERIMENTAL
Intervention: Korean Red Ginseng (KRG)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 35731251

Group type: EXPERIMENTAL
Intervention: Solifenacin added to intradetrusor injections of BoNT A
Number of subjects: 49

Group type: COMPARATOR
Intervention: Intradetrusor injections of BoNT A
Number of subjects: 49
Study: 33048179

Group type: EXPERIMENTAL
Intervention: Pudendal neuromodulation combined with pudendal nerve release using the ENTRAMI technique
Number of subjects: 16
Study: 32181236

Group type: EXPERIMENTAL
Intervention: Category 1 patients (strong genetic basis)
Number of subjects: 258399

Group type: EXPERIMENTAL
Intervention: Category 2 patients (suspected genetic component)
Number of subjects: 258399

Group type: COMPARATOR
Intervention: Category 3 patients (no genetic disease)
Number of subjects: 258399
Study: 34368888

Group type: EXPERIMENTAL
Intervention: Skills treatment (TX) workshops
Number of subjects: 128

Group type: COMPARATOR
Intervention: Education control (EC) workshops
Number of subjects: 128

Group type: COMPARATOR
Intervention: Wait list (WL)
Number of subjects: 128
Study: 33691284

Group type: EXPERIMENTAL
Intervention: HIIT at Middle
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: HIIT at End
Number of subjects: 16

Group type: COMPARATOR
Intervention: HIIT at Beginning
Number of subjects: 16
Study: 32877981

Group type: EXPERIMENTAL
Intervention: Infliximab (INF group)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Methotrexate (MTX group)
Number of subjects: 80
Study: 35179337

Group type: EXPERIMENTAL
Intervention: Sirolimus-coated balloon angioplasty (MagicTouch, Concept Medical)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Paclitaxel-coated balloon angioplasty (Ranger, Boston Scientific)
Number of subjects: 6
Study: 34461961

Group type: EXPERIMENTAL
Intervention: Teriparatide (20 ?g/day) for 16 weeks, continuing to 24 weeks if fracture remains unhealed
Number of subjects: 136

Group type: COMPARATOR
Intervention: Usual Army standard care
Number of subjects: 136
Study: 33030269

Group type: EXPERIMENTAL
Intervention: 900 mL blood donation
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 450 mL blood donation
Number of subjects: 21

Group type: COMPARATOR
Intervention: Sham donation of 900 mL
Number of subjects: 21

Group type: COMPARATOR
Intervention: Sham donation of 450 mL
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Plasma proANP after 900 mL blood donation
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Plasma proANP after 450 mL blood donation
Number of subjects: 21

Group type: COMPARATOR
Intervention: Plasma proANP after sham donation of 900 mL
Number of subjects: 21

Group type: COMPARATOR
Intervention: Plasma proANP after sham donation of 450 mL
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Stroke volume after 900 mL blood donation
Number of subjects: 21
Study: 35409466

Group type: EXPERIMENTAL
Intervention: Web-based intervention group with activity tracker (AG)
Number of subjects: 551

Group type: EXPERIMENTAL
Intervention: Web-based or print-based intervention group (IG)
Number of subjects: 551

Group type: COMPARATOR
Intervention: Waitlist control group (CG)
Number of subjects: 551
Study: 35143714

Group type: EXPERIMENTAL
Intervention: Full-mouth disinfection (FMD) with chlorhexidine
Number of subjects: 42

Group type: COMPARATOR
Intervention: Quadrant-based scaling and root planing (Q-SRP)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Full-mouth scaling and root planing (FM-SRP)
Number of subjects: 42
Study: 34120401

Group type: EXPERIMENTAL
Intervention: Access to the Dental Trauma Guide (DTG)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Standard undergraduate curriculum without DTG access
Number of subjects: 21
Study: 33064711

Group type: EXPERIMENTAL
Intervention: 75 mg pregabalin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 33888251

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 2890

Group type: COMPARATOR
Intervention: Usual Care plus Microfinance (MF)
Number of subjects: 2890

Group type: COMPARATOR
Intervention: Group Medical Visits (GMV)
Number of subjects: 2890

Group type: COMPARATOR
Intervention: GMV integrated into MF (GMV‐MF)
Number of subjects: 2890
Study: 32445322

Group type: EXPERIMENTAL
Intervention: Thermoplastic pelvic mask
Number of subjects: 35

Group type: COMPARATOR
Intervention: Knee wedge
Number of subjects: 35
Study: 33065953

Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 40 U (20 U to frontalis and 20 U to glabellar complex)
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 40 U
Number of subjects: 391

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 391
Study: 34032799

Group type: EXPERIMENTAL
Intervention: Interactive Video Gaming (IVG) group, 12-week intervention, 2 x 1 hour sessions weekly
Number of subjects: 45

Group type: COMPARATOR
Intervention: Conventional Multimodal (CM) group, 12-week intervention, 2 x 1 hour sessions weekly
Number of subjects: 45
Study: 36482142

Group type: EXPERIMENTAL
Intervention: Linguistically appropriate printed decision aid
Number of subjects: 48

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 48
Study: 34115076

Group type: EXPERIMENTAL
Intervention: Hydraulic device and nanohydroxylapatite paste (Ostim) for sinus floor elevation
Number of subjects: 110
Study: 36346729

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (5 mg infusion, once at the start of the study)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 32282432

Group type: EXPERIMENTAL
Intervention: Subcutaneous nitroglycerin (5 μg/kg in 0.5 ml)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Normal saline (0.5 ml)
Number of subjects: 113
Study: 36457044

Group type: EXPERIMENTAL
Intervention: InTSHA (Interactive Transition Support for Adolescents Living with HIV) mHealth intervention
Number of subjects: 21
Study: 33483269

Group type: COMPARATOR
Intervention: Thoracic Epidural Analgesia (TEA)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Serratus Anterior Plane Block (SAPB)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Erector Spinae Plane Block (ESPB)
Number of subjects: 51
Study: 35019221

Group type: EXPERIMENTAL
Intervention: linaclotide (290 μg/d)
Number of subjects: 659

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 659
Study: 33239245

Group type: EXPERIMENTAL
Intervention: Single low-dose ketamine infusion of 0.5 mg/kg
Number of subjects: 73
Study: 35084613

Group type: EXPERIMENTAL
Intervention: COMPAS program (experimental group)
Number of subjects: 2047

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2047
Study: 34767655

Group type: EXPERIMENTAL
Intervention: CSE training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 32519588

Group type: EXPERIMENTAL
Intervention: Mental fatigue task
Number of subjects: 30

Group type: COMPARATOR
Intervention: Watching a documentary (Control)
Number of subjects: 30
Study: 36410832

Group type: EXPERIMENTAL
Intervention: Adaptive e-learning intervention
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Non-adaptive e-learning intervention
Number of subjects: 275

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 275
Study: 34959813

Group type: EXPERIMENTAL
Intervention: Breakfast Consumption (BC) - daily standardized breakfast consumption (energy content: 25% of resting metabolic rate) before 09:00
Number of subjects: 0

Group type: COMPARATOR
Intervention: Breakfast Omission (BO) - no energy-providing nutrients consumed until 10:30
Number of subjects: 0
Study: 32185990

Group type: EXPERIMENTAL
Intervention: Shaoyang Xibi decoction (SYXBD)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Meloxicam
Number of subjects: 66
Study: 33605864

Group type: COMPARATOR
Intervention: GST T1 null genotype
Number of subjects: 0

Group type: COMPARATOR
Intervention: IRS-1 TT genotype
Number of subjects: 0

Group type: COMPARATOR
Intervention: M1-null genotype of GST
Number of subjects: 0